EGF antibody (C-Term)
Quick Overview for EGF antibody (C-Term) (ABIN2257857)
Target
See all EGF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 939-967, C-Term
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- EGF, CT (EGF, Pro-epidermal growth factor, Epidermal growth factor, Urogastrone)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogen
- EGF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 939-967 amino acids from the C-terminal region of human EGF.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Alternative Name
- EGF
-
NCBI Accession
- NP_001954
-
UniProt
- P01133
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-